Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial
Conclusion:
Tamoxifen exerted only a modest effect on attenuate progression for 6 months in this small trial. Additional larger scale studies should be necessary to confirm whether enhancing autophagy can attenuate ALS progression.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Trial/Experimental Study Source Type: research
More News: ALS | Brain | Clinical Trials | Genetics | Internal Medicine | Motor Neurone Disease | Neurology | Sarcomas | Statistics | Study | Tamoxifen